CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Medilync has developed INSULYNC, an integrated medical device that simplifies diabetes management by combining glucose measurement and insulin delivery. It allows real-time data sharing with healthcare providers, improving treatment adherence and patient outcomes.
Medilync is a start-up based in Iceland and founded in 2012 with the goal of revolutionizing the management and treatment of diabetes.
Medilync has created a medical device that simplifies the way patients manage glucose measurement and insulin delivery.
Diabetes requires a highly-disciplined routine of glucose control and insulin injections, being lack of accuracy and of recordkeeping one of the main reasons for a deteriorating health.
There are about 60 million people with diabetes in the EU a…
MEDILYNC EHF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
